How do you differentiate between pulmonary hypertension and pulmonary thromboembolism if the presenting symptoms are almost similar?
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Now I have enough information from the textbooks to synthesize a comprehensive, well-structured answer.
Differentiating pulmonary hypertension (PH) from pulmonary thromboembolism (PE) can be genuinely challenging because both conditions share overlapping symptoms — dyspnea, chest pain, reduced exercise tolerance, hypoxemia, and right heart strain. The key is a systematic, multi-modal approach.
Shared Presenting Symptoms
Both conditions can present with:
- Dyspnea (exertional or at rest)
- Chest pain — substernal or pleuritic
- Syncope or presyncope
- Fatigue, hypoxemia
- Right ventricular (RV) dysfunction
As Murray & Nadel's notes, PH can cause substernal crushing chest pain resembling myocardial ischemia due to RV overload and compression of the left main coronary artery by a dilated pulmonary trunk. However, PE-associated pain is much more commonly pleuritic in character, whether or not pulmonary infarction is present — this is an important early clinical clue.
Key Differentiating Features
1. Clinical Context & Onset
| Feature | PH | PE |
|---|---|---|
| Onset | Insidious, progressive over months–years | Acute or subacute (hours to days) |
| Risk factors | Connective tissue disease, HIV, portal hypertension, congenital heart disease, prior PE | DVT, immobility, surgery, malignancy, pregnancy, hypercoagulable state |
| Symptom duration before diagnosis | Often >6–12 months | Usually <2 weeks |
| Prior PE history | May be present (especially CTEPH) | Common precipitant |
A diagnostic hallmark of chronic thromboembolic PH (CTEPH) is a typical delay in diagnosis — symptoms began more than 2 weeks before the onset of anticoagulation. — Murray & Nadel's Textbook of Respiratory Medicine
2. Chest Pain Character
- PH: Substernal, constricting, may radiate to neck/arms — mimics angina (from RV ischemia and/or compression of the left main coronary artery)
- PE: More commonly pleuritic — sharp, worse with inspiration, often localized — Murray & Nadel's explicitly states embolism pain is "much more likely to be pleuritic in character"
3. Electrocardiography (ECG)
| Feature | PH | PE |
|---|---|---|
| RVH pattern | Classic (R-axis deviation, tall R in V1) | Rare (only in massive PE) |
| S1Q3T3 | Absent | Present (acute cor pulmonale pattern) |
| Sinus tachycardia | Present | Present |
| RV strain | Chronic, stable | Acute, dramatic |
PH shows evidence of right ventricular hypertrophy (RVH) on ECG/echo due to chronic pressure overload. PE shows acute RV strain — the classic S1Q3T3 pattern or new right bundle branch block.
4. Biomarkers
| Biomarker | PH | PE |
|---|---|---|
| D-dimer | Normal or mildly elevated | Elevated (sensitive but not specific) |
| BNP / NT-proBNP | Chronically elevated (marker of RV failure) | Acutely elevated in massive/submassive PE |
| Troponin | Elevated only in advanced disease | Elevated in massive PE |
| Heart-type FABP | May be elevated in CTEPH | Elevated in massive PE |
An elevated NT-proBNP or heart-type fatty acid binding protein at the time of acute PE presentation was associated with increased likelihood of developing CTEPH later — Murray & Nadel's.
5. Imaging
Chest X-Ray
| Finding | PH | PE |
|---|---|---|
| Prominent central PA | Yes, chronically enlarged | Only in massive PE |
| Peripheral oligemia (Westermark sign) | Diffuse | Focal (Westermark's sign) |
| Hampton's hump | Absent | Present (wedge-shaped infarct) |
| Pleural effusion | Uncommon | Possible (with infarction) |
CT Pulmonary Angiography (CTPA)
- CTPA is the test of choice for PE — sensitivity 83–96%, specificity 96% (PIOPED II) — Murray & Nadel's
- In PE: filling defects within pulmonary arteries (central, lobar, segmental)
- In CTEPH: web-like filling defects, chronic organized thrombus, vessel recanalization, mosaic attenuation
- In PAH: dilated main pulmonary arteries, pruned peripheral vasculature — no filling defects
Ventilation-Perfusion (V/Q) Scan
- PE: Segmental V/Q mismatch (ventilated but not perfused) — a high-probability scan is 97% specific for PE (PIOPED I)
- PH: Diffuse perfusion abnormalities or normal; in CTEPH, multiple mismatched perfusion defects may persist even after months of anticoagulation
Echocardiography
| Finding | PH | PE (acute massive) |
|---|---|---|
| RV dilation | Chronic, with hypertrophy | Acute, without hypertrophy |
| RV wall thickness | Increased (>5 mm) | Normal |
| TR jet velocity | Elevated (>3.4 m/s suggests PH) | Acutely elevated |
| McConnell's sign | Absent | Present (RV free wall hypokinesis with apical sparing) |
| Estimated PASP | Chronically >40 mmHg | Elevated acutely |
Doppler echo screening shows PASP >40 mmHg in PH, but right heart catheterization (RHC) is the gold standard to confirm PH — required to assess severity, evaluate ventricular function, and guide therapy. — Goldman-Cecil Medicine
6. Right Heart Catheterization (RHC)
This is the definitive test for PH and also helps exclude PE-related causes:
- PAH (WHO Group 1): mPAP ≥25 mmHg, PCWP ≤15 mmHg, elevated PVR
- PH due to left heart disease (Group 2): elevated PCWP
- CTEPH (Group 4): elevated PAP with imaging evidence of organized thrombus
- In acute PE: may show elevated PAP but RVH is absent; the clinical picture is acute
Administration of vasodilators (e.g., IV nitroprusside) during RHC can help distinguish pulmonary venous hypertension from intrinsic pulmonary vascular disease. — Braunwald's Heart Disease
7. Diagnostic Algorithm Summary
Acute onset + pleuritic chest pain + DVT risk factors
→ Wells score → D-dimer → CTPA → PE diagnosis
Gradual onset + dyspnea on exertion + progressive course
→ Echo (PASP, RVH) → V/Q scan → CTPA → RHC → PH classification
If CTPA shows no acute thrombus but V/Q shows mismatched perfusion defects persisting >3 months after anticoagulation, CTEPH (WHO Group 4 PH) should be suspected — a surgically curable form of PH via pulmonary thromboendarterectomy (PTE). — Murray & Nadel's
Quick Reference Summary Table
| Parameter | Acute PE | Pulmonary Hypertension |
|---|---|---|
| Onset | Acute | Insidious |
| Chest pain | Pleuritic | Angina-like (substernal) |
| D-dimer | Elevated | Normal/mildly elevated |
| ECG | S1Q3T3, acute RV strain | RVH, R-axis deviation |
| Echo | Acute RV dilation, McConnell's sign | Chronic RVH, dilated PA |
| CTPA | Filling defects (clot) | Dilated PA, no filling defects (PAH); chronic webs (CTEPH) |
| V/Q scan | Segmental mismatch | Normal or diffuse; segmental mismatch in CTEPH |
| RHC | Acute elevated PAP, normal PVR (initially) | Chronically elevated PAP + PVR |
| Definitive Dx | CTPA | Right heart catheterization |
Bottom line: The most practical initial differentiating tools are onset and character of symptoms (acute/pleuritic = PE; insidious/angina-like = PH), D-dimer + Wells score for PE, and echocardiography for both. CTPA confirms PE; RHC confirms and classifies PH. CTEPH sits at the intersection — it is a form of PH caused by unresolved PE, requiring V/Q scanning and CTPA together for accurate diagnosis.
This is a shared conversation. Sign in to Orris to start your own chat.